Log In
Copyright © 2016 American Chemical Society
December 5, 2016 Cover
Volume 94, Issue 48
» Full Article
Volume 94, Issue 48
Millionaires, mergers, mosquitos, and more made for big stories in 2016
December 5, 2016 Issue
Volume 94, Issue 48
December 5, 2016 Issue, Vol. 94 | Iss. 48
Millionaires, mergers, mosquitos, and more made for big stories in 2016
(p.36)
Features
Science & Technology
Largest clinical trial in seven years to test the efficacy of an HIV vaccine is kicking off in South Africa (pp. 18-21)
Business
Under Chief Technology Officer David Bem, a growing research force leverages acquisitions and technology to invent new paints (pp. 24-25)
Cover Story: Pharma year in review
Behind the EpiPen
As headlines screamed controversy, a quiet evolution continued in drug pricing
(p.37)Zika response in full gear
Efforts to combat the outbreak yielded diagnostics and first vaccine trials
(p.38)After the upset
Mixed signals and unanswered questions in the wake of Trump’s victory
(p.40)Eteplirsen controversy hit FDA
Approval of Sarepta’s Duchenne drug raised worries that the agency is too lenient
(p.41)Moonshot mania
Large investments in biomedical networks proliferated in 2016
(p.42)Breakup of Pfizer and Allergan shaped the year
Smaller deals filled the void left by a megamerger that wasn’t to be
(p.43)A focus on data
Regulators got serious with firms that modify manufacturing records
(p.44)News of the Week
Boron nitride unexpectedly converts propane to propene
Low-cost, metal-free material shows promise as catalyst for key hydrocarbon conversion reaction
(p.5)ACS journals enact new safety policy
Authors to be required to address novel or significant hazards
(p.7)Names for elements 113, 115, 117, and 118 finalized by IUPAC
Nihonium, moscovium, tennessine, and oganesson complete the seventh row of the periodic table
(p.7)Solar device desalinates water efficiently
Thermal insulator boosts performance by protecting the device’s sunlight absorber from heat loss
(p.8)Turning blood cells into light-controlled drug carriers
Researchers store drugs in red blood cells as vitamin B12 conjugates and release them with light
(p.8)Companies invest in aquaculture ingredients
BASF, Cargill, Calysta advance alternatives to wild fish
(p.12)Japanese firms eye shale gas revolution
Petrochemical joint venture will import propane as new raw material
(p.12)Axial Biotherapeutics launches with neuroscience focus
New microbiome firm connects gut microbes with autism and Parkinson’s disease
(p.13)EPA flexes muscle under new TSCA
Agency picks first 10 chemicals, including asbestos, for safety evaluation
(p.13)Group grades retailers on safer chemicals in products
Walmart, Target get highest marks for reducing priority chemicals of concern
(p.13)Patheon acquires a Roche facility
South Carolina plant will beef up pharmaceutical service firm’s chemical side
(p.13)ACS among science organizations calling for Trump to appoint a science adviser
Groups ask president-elect to prioritize science in transition
(p.16)Departments
Business
Among the city’s growing pains, housing costs are rising and laboratory space is becoming tight
(pp. 22-23)
Under Chief Technology Officer David Bem, a growing research force leverages acquisitions and technology to invent new paints
(pp. 24-25)
As headlines screamed controversy, a quiet evolution continued in drug pricing
(p.37)
Efforts to combat the outbreak yielded diagnostics and first vaccine trials
(p.38)
Mixed signals and unanswered questions in the wake of Trump’s victory
(p.40)
Approval of Sarepta’s Duchenne drug raised worries that the agency is too lenient
(p.41)
Large investments in biomedical networks proliferated in 2016
(p.42)
Millionaires, mergers, mosquitos, and more made for big stories in 2016
(p.36)
Smaller deals filled the void left by a megamerger that wasn’t to be
(p.43)
Regulators got serious with firms that modify manufacturing records
(p.44)Concentrates
(pp. 14-15)
(pp. 14-15)- Pfizer invests in U.S., eases up in Ireland
- Linde, Praxair merger talks back on again
- Evonik clinches deal for biobased methionine
- CEFIC bemoans EU disclosure ruling
- Waters, Bruker back phenotype network
- Drug firm may have used tainted heparin
- Adidas kicks off spider silk shoes
- Givaudan expands in Singapore
- Sanofi gets Warp Drive aminoglycosides
- J&J negotiates to buy Actelion
- Arrowhead sheds programs, staff
- MedImmune, Abpro form research venture
- Business Roundup
ACS News
NCW 2016 showcases chemistry’s role in solving mysteries
(pp. 46-49)
Education
Dow and the University of Michigan’s case study project gives chemistry grad students a taste of industrial research
(pp. 28-29)
Science & Technology
Natural products chemist says plant compounds could repel mosquitoes better than DEET
(pp. 26-27)
Largest clinical trial in seven years to test the efficacy of an HIV vaccine is kicking off in South Africa
(pp. 18-21)
In seeking to understand how people rate risks, psychologists break the big question down into many small ones
(pp. 31-32)
Este material, barato y sin metales, es una opción prometedora en la conversión catalítica de hidrocarburos
(p.5)Concentrates(pp. 10-11)
(pp. 10-11)Career & Employment
A lifelong love of learning moved this chemist from lab bench to newsroom to classroom
(p.34)Newscripts
Editor's Page
Most popular
Viewed
Commented
Chemistry Job Listings